// App-Quantinova.ai

P153 : Tocilizumab in systemic sclerosis: real world experience from a single centre cohort supports potential benefit on lung function for anti-topoisomerase (Scl-70) positive subgroup

Researchers

Presenter

  • Kristina E. N Clark

Principal Investigators

  • Yasir Suleman

  • Svetlana I Nihtyanova

  • Voon H Ong

  • Christopher P Denton

Medical Centers

  • Centre for Rheumatology and Connective Tissue Diseases, Royal Free Hospital, London, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Inflammatory Arthritis

  • Scleroderma

Biomarkers

  • N/A

Drug/Treatment

  • Tocilizumab

Outcome

  • N/A

Study Design

  • Cohort

  • Single Center

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved